Literature DB >> 4859402

Lymphocyte stimulation in urologic cancer patients.

W J Catalona, J L Tarpley, P B Chretien, J R Castle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4859402     DOI： 10.1016/s0022-5347(17)59734-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  The Makari skin test and immunocompetence in bladder cancer.

Authors:  J R Masters; C C Rigby; K W Munson; D E Tee
Journal:  Urol Res       Date:  1980

2.  Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.

Authors:  T Morita; A Tokue; N Minato
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.

Authors:  S Ikemoto; S Wada; M Kamizuru; N Hayahara; T Kishimoto; M Maekawa
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

5.  Bladder instillation of adriamycin in the treatment of bladder cancer.

Authors:  C H Huang; C P Chiang
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Prognostic significance of peritumoural inflammation in invasive urothelial bladder carcinoma.

Authors:  M J Mihatsch; M Rist; T Romppanen; G Rutishauser
Journal:  Urol Res       Date:  1979-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.